Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge
How it worksResultsPricingMeet StoptieCompareBlog
Sign InStart Free Trial
Stoptions.ai
Powered by Amora Edge

Algorithmic scanning across the S&P 500 & Nasdaq 100. Stock & Options trade cards in your inbox by 9:35 AM ET every trading day.

Product
  • How it works
  • The Algorithm
  • Ticker Setups
  • Pricing
  • Morning Brief
  • Results
  • Compare tools
Account
  • Sign In
  • Start Free Trial
  • Give a gift
  • Dashboard
  • Settings
Company
  • About
  • Contact
  • Support
  • Blog
  • Sitemap
Legal
  • Terms of service
  • Privacy policy
  • Risk disclosure
  • Unsubscribe

© 2026 Stoptions.ai · All Rights Reserved

Not financial advice. Algo-generated setups are not personalised investment advice. Options trading involves significant risk of loss — past performance does not guarantee future results.

Chat with Stoptie
Stoptions.ai›Tickers›EW
Last updated: Friday, May 22, 2026 · 9:31 AM ET
↻ Next update: Monday, May 25, 2026 · 9:31 AM ET

EWStock and Options Trade Setup — Edwards Lifesciences CorporationEW logo

NYSE · Structural Heart & Critical Care Medical Devices · Moderate-liquidity options · Large cap · ~$42B

▲ Bullish setupHealth CareMedical devicesLow risk↑ Score +4 vs last update
73
Amora Edge Score
73
Top 28% of today's scan
↑ +4 vs last update
Composite of EMA, RSI, RS vs SPY & volume · updated every 72h
71
EW Win Rate
71%
8 of 11 EW setups hit target in 2026
Tracks completed Stoptions setups on this ticker since Jan 2026
Why we cover EW

Edwards Lifesciences is a pure-play structural heart compounder with one of the most defensible market positions in all of medical devices — its SAPIEN TAVR platform holds roughly 50% global market share in a procedure growing 10–15% annually as cardiologists expand indication to lower-risk and younger patients. The total addressable market remains underpenetrated; millions of patients globally with severe aortic stenosis are still being managed conservatively rather than treated. TAVR procedure volumes are driven by aging demographics and guideline expansion — both secular and durable. The company is also expanding into mitral and tricuspid valve therapies, a market with a potentially larger total addressable market than TAVR. Gross margins above 77% and a clear leader-follower competitive dynamic (versus Abbott and Medtronic) make EW a high-quality, high-margin growth compounder.

Score History & Signal Changelog

Preview data

This page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.

Score progression across 4 updates
Solid = composite · dashed = components
Signal Changelog
DateUpdateScoreDeltaKey change
May 5#1 Created61—Page created. EMA cross on TAVR procedure volume inflection post-Q1 earnings.
May 9#2 Update65+4Healthcare rotation supportive. Mitral/tricuspid pipeline commentary positive.
May 14#3 Update69+4Volume above average. RSI strengthening into momentum zone.
May 19#4 Current73+4All signals active. Structural heart leadership confirmed; setup elevated to Strong.

Signal Breakdown

EMA Cross
Active
19/25
Above both EMAs; consistent uptrend with 20-day acting as support
RSI Zone
Active
18/25
RSI at 62 — strong momentum zone; TAVR procedure volume data supportive
RS vs SPY
Active
18/25
Outperforming SPY +2.7pp; healthcare devices sector rotation supportive
Volume Surge
Active
18/25
1.6× 20-day avg; institutional accumulation on TAVR growth narrative

Today's Trade Card

Setup
EW $80 CALL
Expires Jul 18, 2026
Premium
$2.40
Target
+65% premium
Stop loss
-42% premium
Breakeven
$82.4
Win prob.
56%
Sizing: Risk ≤ 1% of account
Greeks
Delta
0.40
Theta
-0.05
IVR
22%
IVR class
Low
Loading…

Options Profile

Avg IV (30d)
28%
IVR range (52-wk)
16–46%
Put/call ratio
0.78
Avg daily vol.
6K contracts
Open interest
72K contracts
Next earnings
Jul 24, 2026 (est.)

Risks & Fundamentals

Every setup carries risk. Here's what could move EW against you, plus the key stats that frame any position.

Beta
0.8
Market cap
~$42B
Risk level
Low risk
Next earnings
Jul 24, 2026 (est.)
Key risks to monitor
  • 1.TAVR competitive pressure from Abbott Structural Heart (Navitor) and Medtronic (Evolut FX+) is intensifying in lower-risk patient segments
  • 2.Mitral/tricuspid valve therapies are still early-stage — clinical data timelines and reimbursement pathways are uncertain
  • 3.Hospital procedure volume slowdowns (labor shortages, capacity constraints) can create quarterly revenue volatility
These are real risks to the long thesis, not a recommendation to short. Stoptions setups are short-dated and stop-protected; size accordingly.

EW Options Setup — Frequently Asked Questions

Is EW a good options trade today?+

Edwards Lifesciences Corporation (EW) currently has an Amora Edge Score of 73/100, ranking it top 28% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.

What is EW's win rate on Stoptions.ai setups?+

EW's historical win rate on closed Stoptions setups is 71%. Win rate is calculated as the percentage of past EW trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.

What strike and expiry does Stoptions.ai suggest for EW?+

The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.

How often is the EW setup updated?+

Every 72 hours we refresh EW's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If EW drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.

What does the Amora Edge Score measure for EW?+

The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to EW: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is EW outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. EW currently scores 73.

How does EW compare to other Structural Heart & Critical Care Medical Devices setups?+

EW's sector rank and percentile against other Structural Heart & Critical Care Medical Devices tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Structural Heart & Critical Care Medical Devices Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.

Educational content only — not personalized investment advice. Options carry substantial risk.

The Weekly · Free

Get a Friday Recap Including Setups Like EW.

Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.

No spam. One email Friday afternoon. Unsubscribe in one click.

More from Stoptions.ai
← All tickersBrowse by sectorHow the algorithm worksMorning BriefResultsPricing